AMIX Quote, Financials, Valuation and Earnings

Perspective Therapeutics has a net margin of -- compared to Autonomix Medical's net margin of --. Autonomix Medical's return on equity of -- beat Perspective Therapeutics's return on equity of --.

Autonomix Medical has a consensus price target of $18.00, signalling upside risk potential of 967.62%. On the other hand Perspective Therapeutics has an analysts' consensus of $14.39 which suggests that it could grow by 638.1%. Given that Autonomix Medical has higher upside potential than Perspective Therapeutics, analysts believe Autonomix Medical is more attractive than Perspective Therapeutics.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.199, suggesting its more volatile than the S&P 500 by 19.866%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than Perspective Therapeutics quarterly revenues of --. Autonomix Medical's net income of -$2.7M is higher than Perspective Therapeutics's net income of -$40.2M. Notably, Autonomix Medical's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 12.62x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

InfuSystems Holdings has a net margin of -- compared to Autonomix Medical's net margin of 2.76%. Autonomix Medical's return on equity of -- beat InfuSystems Holdings's return on equity of 4.33%.

Autonomix Medical has a consensus price target of $18.00, signalling upside risk potential of 967.62%. On the other hand InfuSystems Holdings has an analysts' consensus of $14.13 which suggests that it could grow by 183.64%. Given that Autonomix Medical has higher upside potential than InfuSystems Holdings, analysts believe Autonomix Medical is more attractive than InfuSystems Holdings.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison InfuSystems Holdings has a beta of 1.898, suggesting its more volatile than the S&P 500 by 89.81%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystems Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. InfuSystems Holdings pays out -- of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than InfuSystems Holdings quarterly revenues of $33.8M. Autonomix Medical's net income of -$2.7M is lower than InfuSystems Holdings's net income of $933K. Notably, Autonomix Medical's price-to-earnings ratio is -- while InfuSystems Holdings's PE ratio is 49.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 0.80x for InfuSystems Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Retractable Technologies has a net margin of -- compared to Autonomix Medical's net margin of -18.58%. Autonomix Medical's return on equity of -- beat Retractable Technologies's return on equity of -16.83%.

Autonomix Medical has a consensus price target of $18.00, signalling upside risk potential of 967.62%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Autonomix Medical has higher upside potential than Retractable Technologies, analysts believe Autonomix Medical is more attractive than Retractable Technologies.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Retractable Technologies has a beta of 2.279, suggesting its more volatile than the S&P 500 by 127.852%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. Retractable Technologies pays out -1.94% of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than Retractable Technologies quarterly revenues of $10.3M. Autonomix Medical's net income of -$2.7M is lower than Retractable Technologies's net income of -$1.9M. Notably, Autonomix Medical's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 0.62x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -- compared to Autonomix Medical's net margin of -10.04%. Autonomix Medical's return on equity of -- beat Xtant Medical Holdings's return on equity of -35.34%.

Autonomix Medical has a consensus price target of $18.00, signalling upside risk potential of 967.62%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 329.98%. Given that Autonomix Medical has higher upside potential than Xtant Medical Holdings, analysts believe Autonomix Medical is more attractive than Xtant Medical Holdings.

Autonomix Medical has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.033, suggesting its less volatile than the S&P 500 by 103.341%.

Autonomix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Autonomix Medical quarterly revenues are --, which are smaller than Xtant Medical Holdings quarterly revenues of $31.5M. Autonomix Medical's net income of -$2.7M is higher than Xtant Medical Holdings's net income of -$3.2M. Notably, Autonomix Medical's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical is -- versus 0.46x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.